Dendritic cell-based vaccines: barriers and opportunities

By Cintolo Jessica A   Datta Jashodeep   Mathew Sarah J   Czerniecki Brian J  

Future Oncology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1273-1299

Future Medicine

Access to resources Recommend Favorite

Dendritic cell-based therapeutic cancer vaccines: what we have and what we need

By Kalinski Pawel   Urban Julie   Narang Rahul   Berk Erik   Wieckowski Ewa   Muthuswamy Ravikumar  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 379-390

Future Medicine

Access to resources Recommend Favorite

Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines

By Ruben Jurjen   Ancker Willemijn   Bontkes Hetty   Westers Theresia   Hooijberg Erik   Ossenkoppele Gert   Gruijl Tanja   Loosdrecht Arjan  

Cancer Immunology, Immunotherapy, Vol. 63, Iss. 4, 2014-04 ,pp. : 335-345

Springer Publishing Company

Access to resources Recommend Favorite

Radiosensitizers in Brain Cancer: Clinical Experience to Date

By Milker-Zabel Stefanie  

American Journal of Cancer, Vol. 5, Iss. 6, 2006-01 ,pp. : 363-370

Adis International

Access to resources Recommend Favorite

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell–based cancer vaccination

By Galea-Lauri Joanna   Wells James   Darling David   Harrison Phillip   Farzaneh Farzin  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 11, 2004-11 ,pp. : 963-977

Springer Publishing Company

Access to resources Recommend Favorite